Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Ensysce Biosciences, Inc. Common Stock (ENSC)

Pharmaceutical Preparations

https://www.ensysce.com

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform.

7946 IVANHOE AVENUE, SUITE 201
LA JOLLA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/01/2021

Market Cap

3,034,068

Shares Outstanding

3,150,000

Weighted SO

3,146,076

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.8500

Last Div

0.0000

Range

0.361-2.06

Chg

0.0068

Avg Vol

124985

Mkt Cap

3034068

Exch

NASDAQ

Country

US

Phone

858 263 4196

DCF Diff

0.6748

DCF

0.1188

Div Yield

0.0000

P/S

2.1100

EV Multiple

-0.2531

P/FV

2.3840

Div Yield %

0.0000

P/E

-0.3127

PEG

-0.0252

Payout

-0.0004

Current Ratio

1.8825

Quick Ratio

2.0541

Cash Ratio

0.7984

DSO

56.9161

DIO

-15.2840

Op Cycle

41.6321

DPO

32.8532

CCC

8.7789

Gross Margin

-2.7239

Op Margin

-6.7190

Pretax Margin

-7.8443

Net Margin

-7.8433

Eff Tax Rate

-0.0325

ROA

-4.0342

ROE

-7.4414

ROCE

-6.4885

NI/EBT

0.9999

EBT/EBIT

1.1675

EBIT/Rev

-6.7190

Debt Ratio

0.1626

D/E

0.3072

LT Debt/Cap

0.0000

Total Debt/Cap

0.2350

Int Coverage

-6.1422

CF/Debt

-16.4434

Equity Multi

1.8897

Rec Turnover

6.4130

Pay Turnover

11.1100

Inv Turnover

-23.8812

FA Turnover

0.0000

Asset Turnover

0.5144

OCF/Share

-0.8475

FCF/Share

-0.8475

Cash/Share

0.1183

OCF/Sales

-5.1970

FCF/OCF

1.0000

CF Coverage

-16.4434

ST Coverage

-16.4434

CapEx Coverage

0.0000

Div&CapEx Cov

-1519.5047

P/BV

2.3840

P/B

2.3840

P/S

2.1100

P/E

-0.3127

P/FCF

-0.4060

P/OCF

-0.4720

P/CF

-0.4720

PEG

-0.0252

P/S

2.1100

EV Multiple

-0.2531

P/FV

2.3840

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation